drugset / Trial / NCT06560489
Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients
Phase 1/2
Completed
40 enrolled
Shanxi Kangbao Biological Product Co., Ltd.
Institute of Pathogen Biology, Beijing, China · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
A Randomized, Double-Blind, Parallel-Group, Exploratory Clinical Study to Evaluate the Safety, Pharmacodynamic Effects, and Pharmacokinetic Characteristics of Multiple Subcutaneous Injections of LP-98 in Treatment-Naive HIV-Infected Individuals
Timeline
- Start
- 2024-09-02
- Primary completion
- 2025-01-10
- Completion
- 2025-08-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LP-98 | Unknown | 1.25 mg | Subcutaneous |
| Subject | LP-98 | Unknown | 2.5 mg | Subcutaneous |
| Subject | LP-98 | Unknown | 5 mg | Subcutaneous |
| Subject | LP-98 | Unknown | 10 mg | Subcutaneous |